1 |
Gali-Muhtasib H, Roessner A, Schneider-Stock R. 2006. Thymoquinone: A promising anti-cancer drug from natural sources. Int J Biochem Cell Biol. 38:1249-1253.
DOI
|
2 |
Ali BH, Blunden G. 2003. Pharmacological and toxicological properties of Nigella sativa. Phytother Res. 17:299-305.
DOI
|
3 |
Cao Z, Liu LZ, Dixon DA, Zheng JZ, Chandran B, Jiang BH. 2007. Insulin-like growth factor-I induces cyclooxygenase- 2 expression via PI3K, MAPK and PKC signaling pathways in human ovarian cancer cells. Cell Signal. 19:1542-1553.
DOI
|
4 |
Costa C, Soares R, Reis-Filho JS, Leitao D, Amendoeira I, Schmitt FC. 2002. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol. 55:429-434.
DOI
|
5 |
El Mezayen R, El Gazzar M, Nicolls MR, Marecki JC, Dreskin SC, Nomiyama H. 2006. Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammation. Immunol Lett. 106:72-81.
DOI
|
6 |
Jemal A, Siegel R, Xu J, Ward E. 2010. Cancer statistics, 2010. CA Cancer J Clin. 60:277-300.
DOI
|
7 |
Lin HY, Sun M, Tang HY, Simone TM,Wu YH, Grandis JR, Cao HJ, Davis PJ, Davis FB. 2008. Resveratrol causes COX-2- and p53-dependent apoptosis in head and neck squamous cell cancer cells. J Cell Biochem. 104:2131-2142.
DOI
|
8 |
O'Banion MK. 1999. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol. 13:45-82.
DOI
|
9 |
Park K, Han S, Shin E, Kim HJ, Kim JY. 2006. Cox-2 expression on tissue microarray of breast cancer. Eur J Surg Oncol. 32:1093-1096.
DOI
|
10 |
Ravindran J, Nair HB, Sung B, Prasad S, Tekmal RR, Aggarwal BB. 2010. Thymoquinone poly (lactideco- glycolide) nanoparticles exhibit enhanced antiproliferative, anti-inflammatory, and chemosensitiza-tion potential. Biochem Pharmacol. 79:1640-1647.
DOI
|
11 |
Schneider A, Stahl RA. 1998. Cyclooxygenase-2 (COX-2) and the kidney: current status and potential perspectives. Nephrol Dial Transplant. 13:10-12.
|
12 |
Shoieb AM, Elgayyar M, Dudrick PS, Bell JL, Tithof PK. 2003. In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. Int J Oncol. 22:107-113.
|
13 |
Smith WL, DeWitt DL, Garavito RM. 2000. Cyclooxygenases: structural, cellular, and molecular biology. Ann Rev Biochem. 69:145-182.
DOI
|
14 |
Smith WL, Garavito RM, DeWitt DL. 1996. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. Critical Rev neurobiol. 271:33157-33160.
|
15 |
Stasinopoulos I, Mori N, Bhujwalla ZM. 2008. The malignant phenotype of breast cancer cells is reduced by COX-2 silencing. Neoplasia. 10:1163-1169.
DOI
|
16 |
St-Germain ME, Gagnon V, Mathieu I, Parent S, Asselin E. 2004. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. Int J Oncol. 24:1311-1324.
|
17 |
Takeda K, Kanekura T, Kanzaki T. 2004. Negative feedback regulation of phosphatidylinositol 3-kinase/Akt pathway by over-expressed cyclooxygenase-2 in human epidermal cancer cells. J Dermatol. 31:516-523.
DOI
|
18 |
Velho-Pereira R, Kumar A, Pandey BN, Jagtap AG, Mishra KP. 2011. Radiosensitization in human breast carcinoma cells by thymoquinone: role of cell cycle and apoptosis. Cell Biol Int. 35:1025-1029.
DOI
|
19 |
Yoon JH, Lim TG, Lee KM, Jeon AJ, Kim SY, Lee KW. 2011. Tangeretin reduces ultraviolet B (UVB)-induced cyclooxygenase-2 expression in mouse epidermal cells by blocking mitogen-activated protein kinase (MAPK) activation and reactive oxygen species (ROS) generation. J Agric Food Chem. 59:222-228.
DOI
|
20 |
Yang T, Huang Y, Heasley LE, Berl T, Schnermann JB, Briggs JP. 2000. MAPK mediation of hypertonicitystimulated cyclooxygenase-2 expression in renal medullary collecting duct cells. J Biol Chem. 275:23281-23286.
DOI
|
21 |
Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn- Ross PL, Rosenthal JF, et al. 1993. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst. 85:1819-1827.
DOI
|